Center for Scientific Review; Notice of Closed Meetings, 52161-52162 [2021-20279]
Download as PDF
<![CDATA[
52161
Federal Register / Vol. 86, No. 179 / Monday, September 20, 2021 / Notices
ANNUALIZED BURDEN HOUR TABLE
Respondents
(If necessary)
Number of
respondents
Number of
responses per
respondents
Average
burden per
response
Total burden
hours
Community and Social Service Occupations (CBO quarterly data entry into
MERD) ..........................................................................................................
Consumers (ETS health lesson learning questionnaires) ...............................
Health care professionals (quarterly data entry in MERD) .............................
Health care professionals (annual focus group) ..............................................
Community and Social Service Occupations (annual focus group) ................
53
63,600
350
16
16
4
1
4
1
1
30/60
10/60
1.5
1.5
1.5
106
10,600
2100
24
24
Total ..........................................................................................................
64,035
........................
........................
12,854
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2021–20276 Filed 9–17–21; 8:45 am]
BILLING CODE 4150–29–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Human Complex Mental Function
Study Section.
Date: October 14–15, 2021
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joanna Szczepanik, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 1000D
Bethesda, MD 20892 (301) 827–2242
szczepaj@csr.nih.gov
Name of Committee: Biology of
Development and Aging Integrated Review
Group; Mechanisms of Cancer
Therapeutics—1 Study Section.
Date: October 18–19, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
16:49 Sep 17, 2021
Jkt 253001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria Dolores Arjona
Mayor, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institute of Health, 6701 Rockledge Drive,
Room 806D, Bethesda, MD 20892, (301) 827–
8578, dolores.arjonamayor@nih.gov.
Name of Committee: Interdisciplinary
Molecular Sciences and Training Integrated
Review Group; Cellular and Molecular
Technologies Study Section.
Date: October 20–21, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tatiana V. Cohen, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213,
Bethesda, MD 20892, 301–455–2364,
tatiana.cohen@nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group; Drug Discovery and Molecular
Pharmacology Study Section.
Date: October 21–22, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jeffrey Smiley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6194,
MSC 7804 Bethesda, MD 20892, 301–594–
7945 smileyja@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Acute Neural Injury and Epilepsy
Study Section.
Date: October 21–22, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Paula Elyse Schauwecker,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201,
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Bethesda, MD 20892, 301–760–8207,
schauweckerpe@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
Clinical Research and Field Studies of
Infectious Diseases Study Section.
Date: October 21–22, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pauline Cupit, Ph.D.,
Scientific Review Office,r Center for
Scientific Review National Institute of
Health, 6701 Rockledge Drive, Bethesda, MD
20892 301–827–3275, cupitcunninghpm@
mail.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Interdisciplinary Clinical Care in Specialty
Care Settings Study Section.
Date: October 21–22, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Abu Saleh Mohammad
Abdullah, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 827–4043,
abuabdullah.abdullah@nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Genomics
Computational Biology and Technology
Study Section.
Date: October 21–22, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge, Drive
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Methode Bacanamwo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200,
Bethesda, MD 20892 301–827–7088,
methode.bacanamwo@nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Clinical Integrative Cardiovascular
and Hematological Sciences Study Section.
Date: October 21–22, 2021.
Time: 9:00 a.m. to 6:00 p.m.
E:\FR\FM\20SEN1.SGM
20SEN1
52162
Federal Register / Vol. 86, No. 179 / Monday, September 20, 2021 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Margaret Chandler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review National Institutes of
Health, 6701 Rockledge Drive, Room 4126,
MSC 7814, Bethesda, MD 20892, (301) 435–
1743, margaret.chandler@nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Auditory System
Study Section.
Date: October 21–22, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Brian H. Scott, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892 301–
827–7490, brianscott@mail.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neurotransporters, Receptors,
and Calcium Signaling Study Section.
Date: October 21, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Peter B. Guthrie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4182,
MSC 7850, Bethesda, MD 20892, (301) 435–
1239 guthriep@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 15, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20279 Filed 9–17–21; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
16:49 Sep 17, 2021
Jkt 253001
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Health, Behavior, and Context
Study Section.
Date: October 18, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2137C,
Bethesda, MD 20892 (Video-Assisted
Meeting).
Contact Person: Kimberly L. Houston,
M.D., Scientific Review Officer, Scientific
Review Branch, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, National Institutes of
Health, 6710B Rockledge Drive, Room 2137C,
Bethesda, MD 20892, (301) 827–4902,
kimberly.houston@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: September 15, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20263 Filed 9–17–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; NIMHD Support for
Conferences and Scientific Meetings (R13).
Date: October 27, 2021.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Gateway Plaza, 7201 Wisconsin Avenue,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Xinli Nan, M.D., Ph.D.,
Scientific Review Officer, Division of
Scientific Programs, National Institute on
Minority Health and Health Disparities,
National Institutes of Health, Gateway
Building, 7201 Wisconsin Avenue, Bethesda,
MD 20892, 301–594–7784, Xinli.Nan@
nih.gov.
Dated: September 15, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20280 Filed 9–17–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket Number USCG–2021–0738]
Offshore Patrol Cutter Acquisition
Program; Draft Programmatic
Environmental Impact Statement/
Overseas Environmental Impact
Statement
Coast Guard, Department of
Homeland Security (DHS).
ACTION: Notice of availability of a Draft
Programmatic Environmental Impact
Statement/Overseas Environmental
Impact Statement; request for
comments.
AGENCY:
The United States (U.S.) Coast
Guard (Coast Guard), as the lead agency,
announces the availability of the Draft
Programmatic Environmental Impact
Statement (PEIS)/Overseas
Environmental Impact Statement
(POEIS) for the Offshore Patrol Cutter
(OPC) Program’s Stage 2 acquisition of
up to 21 OPCs and for the operation of
up to 25 total OPCs. The complete OPC
Program of Record comprises 25 OPCs.
OPC Stage 1 is already under contract to
provide the first 4 OPCs. OPC Stage 2
is the focus of this PEIS/POEIS and will
provide the remaining 21 OPCs. This
PEIS/POEIS is being prepared in
compliance with the National
Environmental Policy Act and the
regulations implemented by the Council
on Environmental Quality (CEQ) and
SUMMARY:
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 86, Number 179 (Monday, September 20, 2021)]
[Notices]
[Pages 52161-52162]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20279]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Human Complex Mental Function Study
Section.
Date: October 14-15, 2021
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joanna Szczepanik, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institute of Health,
6701 Rockledge Drive, Room 1000D Bethesda, MD 20892 (301) 827-2242
[email protected]
Name of Committee: Biology of Development and Aging Integrated
Review Group; Mechanisms of Cancer Therapeutics--1 Study Section.
Date: October 18-19, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria Dolores Arjona Mayor, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 806D, Bethesda, MD 20892, (301)
827-8578, [email protected].
Name of Committee: Interdisciplinary Molecular Sciences and
Training Integrated Review Group; Cellular and Molecular
Technologies Study Section.
Date: October 20-21, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tatiana V. Cohen, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213, Bethesda, MD 20892, 301-
455-2364, [email protected].
Name of Committee: Biology of Development and Aging Integrated
Review Group; Drug Discovery and Molecular Pharmacology Study
Section.
Date: October 21-22, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jeffrey Smiley, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6194, MSC 7804 Bethesda, MD
20892, 301-594-7945 [email protected].
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Acute Neural Injury and Epilepsy Study
Section.
Date: October 21-22, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Paula Elyse Schauwecker, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201, Bethesda, MD 20892, 301-
760-8207, [email protected].
Name of Committee: Infectious Diseases and Immunology B
Integrated Review Group; Clinical Research and Field Studies of
Infectious Diseases Study Section.
Date: October 21-22, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pauline Cupit, Ph.D., Scientific Review Office,r
Center for Scientific Review National Institute of Health, 6701
Rockledge Drive, Bethesda, MD 20892 301-827-3275,
[email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Interdisciplinary Clinical Care in
Specialty Care Settings Study Section.
Date: October 21-22, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Abu Saleh Mohammad Abdullah, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827-4043,
[email protected].
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Genomics Computational Biology and Technology Study
Section.
Date: October 21-22, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge, Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Methode Bacanamwo, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200, Bethesda, MD 20892 301-827-
7088, [email protected].
Name of Committee: Cardiovascular and Respiratory Sciences
Integrated Review Group; Clinical Integrative Cardiovascular and
Hematological Sciences Study Section.
Date: October 21-22, 2021.
Time: 9:00 a.m. to 6:00 p.m.
[[Page 52162]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Margaret Chandler, Ph.D., Scientific Review
Officer, Center for Scientific Review National Institutes of Health,
6701 Rockledge Drive, Room 4126, MSC 7814, Bethesda, MD 20892, (301)
435-1743, [email protected].
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Auditory System Study Section.
Date: October 21-22, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Brian H. Scott, Ph.D., Scientific Review
Officer, National Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Bethesda, MD 20892 301-827-7490,
[email protected].
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Neurotransporters, Receptors,
and Calcium Signaling Study Section.
Date: October 21, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Peter B. Guthrie, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4182, MSC 7850, Bethesda, MD
20892, (301) 435-1239 [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 15, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-20279 Filed 9-17-21; 8:45 am]
BILLING CODE 4140-01-P
